Related Experiment Videos
Vitiligo following type II lepra reaction
1Dept. of Dermatology and Venereology, Medical College Hospital, Kottayam.
Indian Journal of Leprosy
|January 1, 1989
Summary
Leprosy patients may develop vitiligo following lepra reactions, suggesting an autoimmune link. This depigmentation persisted post-treatment and showed partial response to psoralen therapy.
Area of Science:
- Dermatology
- Immunology
- Infectious Diseases
Background:
- Lepromatous leprosy is a chronic infectious disease caused by Mycobacterium leprae.
- Lepra reactions, particularly Type II, involve immune-mediated inflammatory responses.
- Vitiligo is a chronic autoimmune condition characterized by depigmented skin macules.
Observation:
- A middle-aged male with lepromatous leprosy presented with recurrent episodes of vitiligo.
- These vitiligo episodes consistently followed attacks of Type II lepra reaction.
- The depigmented macules persisted even after successful leprosy treatment.
Findings:
- The temporal association suggests a potential autoimmune mechanism linking lepra reactions and vitiligo development.
- The patient's vitiligo showed a partial response to psoralen photochemotherapy.
- This case highlights a possible autoimmune comorbidity in leprosy patients experiencing lepra reactions.
Implications:
- Further research into the autoimmune pathogenesis shared by lepra reactions and vitiligo is warranted.
- Understanding this association may lead to novel therapeutic strategies for both conditions.
- This case underscores the importance of considering autoimmune phenomena in complex leprosy presentations.